A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).

Clinical trial NCT05227209 · TERMINATED

Trial details

NCT number: NCT05227209
Sponsor: Sumitomo Pharma America, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Episodes, Bipolar I Depression

Start date: 2022-03-17
Primary completion: 2023-11-17
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.